Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma), founded in 1994, is a global healthcare group driven by innovation and rooted in China. Its business covers pharmaceuticals, medical devices, medical diagnostics, and healthcare services, while also maintaining a strategic presence in pharmaceutical distribution through its stake in Sinopharm.
Fosun Pharma is committed to becoming a global leader in medical innovation. Its core therapeutic areas focus on oncology, immunology, and inflammation. Through internal R&D, licensed imports, and industry partnerships, the company has established a robust innovation system and holds significant advantages in cell therapy, small molecule drugs, and antibodies. Adhering to its core value of “Innovating for Good Health,” Fosun Pharma continues to drive global growth, striving to bring high-quality medical solutions to patients worldwide.
Market position and competitiors
Below is a list of articles for the company:
-
Fosun Pharma: 2026Q1 Earnings
Fosun Pharma (600196.SH; 02196.HK) released its Q1 2026 financial results on April 28, 2026. The following is a summary of the quarterly report: Financial Highlights (Q1 2026) Business and Strategic Progress Financial Information Source For detailed data, please refer to the official announcement by Fosun Pharma: Q1 2026 Report (PDF) Fosun Pharma (600196.SH; 02196.HK)’s Q1…
-
Fosun pharma: supply chain and competitions
Fosun Pharma holds a leading market position in the Chinese and global healthcare industries, with its industry rankings and market share characteristics reflected across several dimensions: Sources: Fosun Pharma Official Website – Company Honors Citeline Report Fosun Pharma’s supply chain system and key partner layout revolve around the integration of “R&D, manufacturing, and distribution.” Its…
-
Fosun Pharma: History and Business Model
Fosun Pharma’s development history can be broadly divided into the following four stages, illustrating its transformation from a startup into a global innovative healthcare group: I. Founding and Foundation Stage (1994 – 1998) II. Industrial Integration and Diversification Stage (1999 – 2011) III. Innovation-Driven and Global Deepening Stage (2012 – 2020) IV. Global Operations and…